Anti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance

Ilias Stagakis; George Bertsias; Stylianos Karvounaris; Melina Kavousanaki; Dimitra Virla; Amalia Raptopoulou; Dimitrios Kardassis; Dimitrios T Boumpas; Prodromos I Sidiropoulos

doi:10.1186/ar3874

Download references

Anti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance

Ilias Stagakis^†, George Bertsias^†, Stylianos Karvounaris, Melina Kavousanaki, Dimitra Virla, Amalia Raptopoulou, Dimitrios Kardassis, Dimitrios T Boumpas and Prodromos I Sidiropoulos^*

* Corresponding author: Prodromos I Sidiropoulos sidiropp@med.uoc.gr
† Equal contributors

Arthritis Research & Therapy 2012, 14:R141 doi:10.1186/ar3874

Include	Article citation and all cited references Cited references only Article citation only
Format	EndNote, Zotero or Papers Reference Manager Refworks BibTeX

Arthritis Research & Therapy

Viewing options

Associated material

Tools

Share this article

Download references

Anti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance

Arthritis Research & Therapy

Viewing options

Associated material

Related literature

Other articles by authors

Related articles/pages

Tools

Share this article

Email updates

Download references

Anti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance